Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pharmaceutical Equivalents
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Drug Control Governance: Regulatory Bodies and Their Impact
Bioequivalence of Drugs: Drugs with Multiple Indications
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 5, 2026

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
Published on: April 25, 2012
Antoine C G Egberts1, Anthonius de Boer
1Universiteit Utrecht, divisie Farmaco-epidemiologie en Klinische Farmacologie, Utrecht, the Netherlands.
Patient access to essential medications in the Netherlands is strained by complex pharmaceutical funding. Recent changes, including rising drug costs and shifting care responsibilities, necessitate urgent reform of drug budget distribution.
Area of Science:
Context:
Purpose:
Summary:
Impact: